Higher-dose Anakinra Is Effective in a Case of Medically Refractory Macrophage Activation Syndrome

被引：42

作者：

Kahn, Philip J. ^{[1
]}

Cron, Randy Q. ^{[2
]}

机构：

[1] NYU, Sch Med, New York, NY USA

[2] Univ Alabama Birmingham, Childrens Hosp Alabama, Birmingham, AL USA

来源：

JOURNAL OF RHEUMATOLOGY | 2013年 / 40卷 / 05期

关键词：

JUVENILE IDIOPATHIC ARTHRITIS; INTERLEUKIN-1 RECEPTOR ANTAGONIST; CASE SERIES; THERAPY;

D O I：

10.3899/jrheum.121098

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：743 / 744

页数：2

共 12 条

[1]

Behrens EM, 2007, J RHEUMATOL, V34, P1133

[2] Rapid and Sustained Remission of Systemic Juvenile Idiopathic Arthritis-Associated Macrophage Activation Syndrome Through Treatment With Anakinra and Corticosteroids [J].

Bruck, Normi ;

Suttorp, Meinolf ;

Kabus, Maria ;

Heubner, Georg ;

Gahr, Manfred ;

Pessler, Frank .

JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2011, 17 (01) :23-27

[3] RECOMBINANT HUMAN INTERLEUKIN-1 RECEPTOR ANTAGONIST IN THE TREATMENT OF PATIENTS WITH SEPSIS SYNDROME - RESULTS FROM A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL [J].

FISHER, CJ ;

DHAINAUT, JFA ;

OPAL, SM ;

PRIBBLE, JP ;

BALK, RA ;

SLOTMAN, GJ ;

IBERTI, TJ ;

RACKOW, EC ;

SHAPIRO, MJ ;

GREENMAN, RL ;

REINES, HD ;

SHELLY, MP ;

THOMPSON, BW ;

LABRECQUE, JF ;

CATALANO, MA ;

KNAUS, WA ;

SADOFF, JC ;

ASTIZ, M ;

CARPATI, C ;

BONE, RC ;

FREIDMAN, B ;

MURE, AJ ;

BRATHWAITE, C ;

SHAPIRO, E ;

MELHORN, L ;

TAYLOR, R ;

KEEGAN, M ;

OBRIEN, J ;

SCHEIN, R ;

PENA, M ;

WASSERLOUF, M ;

OROPELLO, J ;

BENJAMIN, E ;

DELGUIDICE, R ;

EMMANUEL, G ;

LIE, T ;

ANDERSON, L ;

MARSHALL, J ;

DEMAJO, W ;

ROTSTEIN, O ;

FOSTER, D ;

ABRAHAM, E ;

MIDDLETON, H ;

PERRY, C ;

LEVY, H ;

FRY, DE ;

SIMPSON, SQ ;

CROWELL, RE ;

NEIDHART, M ;

STEVENS, D .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1994, 271 (23) :1836-1843

[4] A case of macrophage activation syndrome successfully treated with anakinra [J].

Kelly, Alison ;

Ramanan, Athimalaipet V. .

NATURE CLINICAL PRACTICE RHEUMATOLOGY, 2008, 4 (11) :615-620

[5] Recognition and management of macrophage activation syndrome in juvenile arthritis [J].

Kelly, Alison ;

Ramanan, Athimalaipet V. .

CURRENT OPINION IN RHEUMATOLOGY, 2007, 19 (05) :477-481

[6] Successful treatment of severe paediatric rheumatic disease-associated macrophage activation syndrome with interleukin-1 inhibition following conventional immunosuppressive therapy: case series with 12 patients [J].

Miettunen, Paivi M. ;

Narendran, Aru ;

Jayanthan, Aarthi ;

Behrens, Edward M. ;

Cron, Randy Q. .

RHEUMATOLOGY, 2011, 50 (02) :417-419

[7] Long-Term Efficacy of the Interleukin-1 Receptor Antagonist Anakinra in Ten Patients With Neonatal-Onset Multisystem Inflammatory Disease/Chronic Infantile Neurologic, Cutaneous, Articular Syndrome [J].

Neven, Benedicte ;

Marvillet, Isabelle ;

Terrada, Celine ;

Ferster, Alice ;

Boddaert, Nathalie ;

Couloignier, Vincent ;

Pinto, Graziella ;

Pagnier, Anne ;

Bodemer, Christine ;

Bodaghi, Bahram ;

Tardieu, Marc ;

Prieur, Anne Marie ;

Quartier, Pierre .

ARTHRITIS AND RHEUMATISM, 2010, 62 (01) :258-267

[8] Role of interleukin-1 (IL-1) in the pathogenesis of systemic onset juvenile idiopathic arthritis and clinical response to IL-1 blockade [J].

Pascual, V ;

Allantaz, F ;

Arce, E ;

Punaro, M ;

Banchereau, J .

JOURNAL OF EXPERIMENTAL MEDICINE, 2005, 201 (09) :1479-1486

[9] Macrophage activation syndrome as part of systemic juvenile idiopathic arthritis: diagnosis, genetics, pathophysiology and treatment [J].

Ravelli, A. ;

Grom, A. A. ;

Behrens, E. M. ;

Cron, R. Q. .

GENES AND IMMUNITY, 2012, 13 (04) :289-298

[10] Combination Therapy of Abatacept and Anakinra in Children with Refractory Systemic Juvenile Idiopathic Arthritis: A Retrospective Case Series [J].

Record, Jessica L. ;

Beukelman, Timothy ;

Cron, Randy Q. .

JOURNAL OF RHEUMATOLOGY, 2011, 38 (01) :179-181

← 1 2 →